Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Pancreatic Neoplasms × zimberelimab × Clear all

Phase

Status

Suspended 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Gemcitabine 4 zimberelimab 1 sotigalimab 1 poly(I).poly(c12,U) 1 palbociclib 1 gedatolisib 1 Tomography, Optical Coherence 1 S 1 (combination) 1 NUC-1031 1 IFL protocol 1 Extracorporeal Shockwave Therapy 1 Erlotinib Hydrochloride 1 Carnitine 1 Calcitriol 1 ABTL0812 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05419479 2026-02-24

Switch Maintenance in Pancreatic

Dana-Farber Cancer Institute

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡